SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 21.81 |
| Enterprise Value ($M) | 1.07 |
| Book Value ($M) | 12.33 |
| Book Value / Share | 1.91 |
| Price / Book | 1.77 |
| NCAV ($M) | 9.65 |
| NCAV / Share | 1.49 |
| Price / NCAV | 2.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.86 |
| Return on Assets (ROA) | -0.73 |
| Return on Equity (ROE) | -5.78 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.11 |
| Current Ratio | 3.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 52.80 |
| Assets | 55.48 |
| Liabilities | 43.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -40.43 |
| Net Income | -38.51 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -29.38 |
| Cash from Investing | -0.21 |
| Cash from Financing | 29.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Cormorant Asset Management, LP | 9.99 | ||
| 13G/A | ADAR1 Capital Management, LLC | 4.91 | -37.77 | |
| 13D/A | Baker Bros. Advisors Lp | 19.70 | 34.84 | |
| 13D | Sr One Capital Management, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,871 | 30,628 | 28.96 | |
| 12,251 | 249,987 | 4.90 | |
| 40,314 | 183,969 | 21.91 | |
| 19,861 | 76,243 | 26.05 | |
| 7,513 | 32,351 | 23.22 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ITRM – Iterum Therapeutics plc | JAGX – Jaguar Health, Inc. |
| JSPR – Jasper Therapeutics, Inc. | KPRX – Kiora Pharmaceuticals, Inc. |
| KRRO – Korro Bio, Inc. |
Financial data and stock pages provided by
Fintel.io